Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exforge versus atenolol + amlodipine for central systolic blood pressure in uncontrolled essential hypertension
2006-006733-41Phase 4Completed
- Sponsor
- Novartis
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of amlodipine + valsartan, atenolol, amlodipine and valsartan in essential hypertension (2 arms), sponsored by Novartis. Primary endpoint: Change in central systolic blood pressure. Started Oct 2007; status: completed.
02
Drugs
amlodipine + valsartanatenololamlodipinevalsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2006-006733-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006733-41.